(Q63577185)
Statements
An Open-label, Multi-center Long-term Safety Roll-over Study in Patients With Tuberous Sclerosis Complex (TSC) and Refractory Seizures Who Are Judged by the Investigator to Benefit From Continued Treatment With Everolimus After Completion of Study CRAD001M2304. (English)
0 references
2 April 2017
0 references
8 July 2027
0 references
206
0 references
2 year
0 references
65 year
0 references